Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections

10.1001/jamanetworkopen.2022.5750

Saved in:

Bibliographic Details
Main Authors:	Park, Minah, Tan, Kelvin Bryan, Vasoo, Shawn, Dickens, Borame L, Lye, David, Cook, Alex R
Other Authors:	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format:	Letter
Language:	English
Published:	AMER MEDICAL ASSOC 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/242820
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-242820
record_format	dspace
spelling	sg-nus-scholar.10635-2428202024-04-17T09:31:50Z Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections Park, Minah Tan, Kelvin Bryan Vasoo, Shawn Dickens, Borame L Lye, David Cook, Alex R DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) MEDICINE Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine 10.1001/jamanetworkopen.2022.5750 JAMA NETWORK OPEN 5 4 2023-07-06T03:27:15Z 2023-07-06T03:27:15Z 2022-04-05 2023-07-05T16:46:18Z Letter Park, Minah, Tan, Kelvin Bryan, Vasoo, Shawn, Dickens, Borame L, Lye, David, Cook, Alex R (2022-04-05). Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections. JAMA NETWORK OPEN 5 (4). ScholarBank@NUS Repository. https://doi.org/10.1001/jamanetworkopen.2022.5750 2574-3805 https://scholarbank.nus.edu.sg/handle/10635/242820 en AMER MEDICAL ASSOC Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine
spellingShingle	Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine Park, Minah Tan, Kelvin Bryan Vasoo, Shawn Dickens, Borame L Lye, David Cook, Alex R Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
description	10.1001/jamanetworkopen.2022.5750
author2	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
author_facet	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) Park, Minah Tan, Kelvin Bryan Vasoo, Shawn Dickens, Borame L Lye, David Cook, Alex R
format	Letter
author	Park, Minah Tan, Kelvin Bryan Vasoo, Shawn Dickens, Borame L Lye, David Cook, Alex R
author_sort	Park, Minah
title	Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
title_short	Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
title_full	Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
title_fullStr	Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
title_full_unstemmed	Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections
title_sort	estimated health outcomes and costs associated with use of monoclonal antibodies for prevention or mitigation of sars-cov-2 infections
publisher	AMER MEDICAL ASSOC
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/242820
_version_	1800915892569112576

Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections

Similar Items